AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
news via Technology - Investor's Business Daily
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat. The post AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge appeared first on Investor's Business Daily....
READ FULL ARTICLE »
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!